Nanomedicine has high potential for early detection of disorders and achieving unprecedented treatment efficacies, even against intractable diseases, by effectively overcoming biological barriers and controlling the function of bioactive agents in the body. In our group, we aim to develop nanomedicines for effective diagnosis and therapy through the precise sensing of targets in the body and the triggering of the nanomedicines' activity at specific sites, modulating the behavior of the loaded drugs, even at the subcellular level.
The aspects involved in the design of successful nanomedicines and the interplay of nanomedicines with the biological interface are major interests of the lab, focusing on the ultimate translation of nanomedicine strategies to humans.
The University of Tokyo, Department of Bioengineering
Bld.#5 , 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656 (MAP)